High Resolution Functional Maps of Enhancer RNA and Subcellular RNA Granules in Human Immune Cells
High Resolution Functional Maps of Enhancer RNA and Subcellular RNA Granules in Human Immune Cells
批准号:
10623195
负责人:
Hojoong Kwak
金额:
$40.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-05-31
关键词:
AddressCellsChromatinChromosome MappingCytoplasmic GranulesDNA Sequence AlterationDiseaseElementsEnhancersFoundationsGene ExpressionGenesGenetic Enhancer ElementGenetic TranscriptionGenetic VariationGenomeGenomicsHigh-Throughput RNA SequencingHumanHuman GenomeImmuneLinkLongevityMapsMembraneMetabolic DiseasesMethodsMissionModificationMolecularOrganellesPhasePoly(A) TailProcessRNARNA ProcessingRNA analysisRegulationResearchResolutionRunningScienceSiteSpecificityTailVariantcancer immunotherapycost efficientexhaustionhuman diseaseimmune activationimprovedinnovationnew therapeutic targetnovelperipheral bloodprecision medicineprogramsspatiotemporalstress granuletemporal measurementtraffickingtranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract/Summary
My research focuses on the precise understanding of the regulation of RNA in living cells and human diseases.
Mapping where the regulations take place is critical in identifying factors and elements that alter RNA
expression. Further enhancing the genomic resolution and the spatiotemporal resolution of RNA expression
have been a strong driver of leading discoveries in molecular and disease mechanisms.
My first focus is to define the high-resolution maps of the transcriptional enhancers in peripheral blood
immune cells, using enhancer RNA (eRNA) as the guide. eRNA transcription is a novel mechanism of which
the RNA is synthesized from enhancer sequences themselves other than their target genes. eRNA has
expanded the previous understanding of how enhancers are constructed and allowed mapping important
subregions within the enhancers in higher resolution. eRNA based maps of enhancers will guide us to more
efficiently discover genomic elements linked to the dysregulation of disease genes, and specifically dissect
causal genetic variations or mutations. This will have a widespread impact on major human diseases, and my
specific focus is on immunometabolic diseases and the impact of enhancer variations at the eRNA start sites.
The second focus is on the subcellular compartments that leads to differential RNA trafficking, processing,
and decay. Membraneless organelles, such as stress granules, are suggested to be the novel mechanism of
gene expression control through phase separation and sequestration. I will explore the idea that spatial
compartmentalization confers specificity of temporal gene expression. In particular, I will dissect the specificity
of RNA processing in stress granules in high temporal resolution in immune cell activation and exhaustion and
explore their linkage to the dysregulation of disease associated genes. This will lead to the discovery of novel
therapeutic targets on the specificity factors during the phase separation process.
To address these, my group harnesses the power of high throughput RNA sequencing methods, and
further tailor them. We developed novel RNA sequencing methods such as Precision Run-On sequencing,
Chromatin Run-On sequencing, Tail End Displacement sequencing, and RNA granule sequencing. These
methods elucidate multiple aspects of RNA mechanism in high throughput: nascent transcription, poly(A) tail
modification, and RNA sequestration. We will continue to improve and develop novel RNA analysis strategies
to dissect eRNA transcription, RNA modifications, and combining these methods with subcellular
compartmentalization in high spatial and temporal resolution in cost efficient manners. These innovations will
lead to enhancements in refining genetic maps and higher spatiotemporal resolution in analyzing RNA
expression. Our mission is to discover critical mechanisms and checkpoints of RNA lifespan, focusing on
eRNA and RNA granules. This will provide foundations to apply the ideas and methods of high-resolution RNA
mapping in further collaborative efforts for advancing the precision medicine of human disease.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41598-023-46415-2
发表时间:
2023-11-04
期刊:
Scientific reports
影响因子:
4.6
作者:
[]
通讯作者:
High Resolution Functional Maps of Enhancer RNA and Subcellular RNA Granules in Human Immune Cells
-
批准号:10276376
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2021
-
负责人:Hojoong Kwak
-
依托单位:
High Resolution Functional Maps of Enhancer RNA and Subcellular RNA Granules in Human Immune Cells
-
批准号:10458771
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2021
-
负责人:Hojoong Kwak
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: